Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Synexus (0) Acquired (2)
colesevelam (welchol) (1 trial)
ezetimibe (zetia) (2 trials)
Key: Synexus (3) Acquired (8)
amlodipine (norvasc) (1 trial)
atorvastatin (lipitor) (4 trials)
canosimibe (1 trial)
celecoxib (celebrex) (1 trial)
diclofenac (voltaren) (2 trials)
eprosartan (teveten) (1 trial)
lidocaine (xylocaine) (1 trial)
meloxicam (mobic) (1 trial)
tetracaine (pontocaine) (1 trial)
traumeel (1 trial)
zeel (1 trial)
Key: Synexus (2) Acquired (16)
alt-2074 (1 trial)
antipyrine (1 trial)
benzocaine (Orajel) (1 trial)
betahistine mesilate (1 trial)
bupropion (wellbutrin) (1 trial)
choline c11 (choline c-11) (1 trial)
cx157 (1 trial)
fenofibrate (fenoglide) (2 trials)
fentanyl (Innovar) (1 trial)
heat-labile enterotoxin of e. coli (2 trials)
icosapent ethyl (vascepa) (1 trial)
ketoprofen (orudis) (1 trial)
lomitapide (juxtapid) (2 trials)
methimazole (tapazole) (1 trial)
omega-3-carboxylic acids (epanova) (1 trial)
peramivir (rapivab) (1 trial)
tmi-358 (1 trial)
zonisamide (Zonegran) (1 trial)
Key: Synexus (0) Acquired (8)
apple (1 trial)
apricot (1 trial)
biotin (1 trial)
chromium tripicolinate (1 trial)
ellagic acid (1 trial)
nectarine (1 trial)
raspberry (1 trial)
vitis vinifera (1 trial)
Essential Hypertension (Phase 3)
Hypertension (Phase 3)
Otitis (Phase 2)
Otitis Media (Phase 2)
Trials (30 total)
Trial APIs (39 total)